[Ip-health] Re: IGWG II: Limitation on Diseases

[Judit Rius Sanjuan]

Dear Mr. Hohman,

Thank you for your email. In this era of blackberries, sms, email and
people going outside of the room to have a coffee, we have access to
knowledge.

I am sure the 49 pharmaceutical companies representatives are equally
well informed, as are biotech who are actually in the room.

Judit

Hohman, David E wrote:
> If you don't have access how do you know it's going on?
>
> -----Original Message-----
> From: ip-health-admin@lists.essential.org <ip-health-admin@lists.essentia=
l.org>
> CC: Ip-health@lists.essential.org <Ip-health@lists.essential.org>
> Sent: Wed Nov 07 12:31:25 2007
> Subject: [Ip-health] Re: IGWG II: Limitation on Diseases
>
> It seems the footnote 1 may be coming back, they are currently
> discussing it in one of the drafting rooms we (NGOS) do not have access t=
o.
>
> Judit Rius Sanjuan wrote:
>
>> We have been informed that yesterday night one of the drafting group
>> agreed to eliminate the footnote 1 included in the Secretariat Draft
>> Global Strategy and Plan of Action.
>>
>> These are very good news because the footnote 1 included a
>> unjustifiable limitation by listing the diseases that will be the
>> focus of this global strategy and plan of action:
>>
>> Footnote eliminated: "The Commission=E2=80=99s definitions of Type I, Ty=
pe II
>> and Type III diseases, and the specific diseases on which this draft
>> strategy focuses, are as follows: Type I diseases are incident in both
>> rich and poor countries, with large numbers of vulnerable populations
>> in each. The strategy will focus on the following Type I diseases,
>> increasingly prevalent in developing countries: diabetes,
>> cardiovascular disease and cancer. Type II diseases are incident in
>> both rich and poor countries, but with a substantial proportion of the
>> cases in poor countries. For the purposes of the strategy, the focus
>> is on HIV/AIDS and tuberculosis. Type III diseases are those that are
>> overwhelmingly or exclusively incident in developing countries. For
>> the purposes of the strategy, the focus is on the nine neglected
>> infectious diseases that disproportionately affect poor and
>> marginalized populations prioritized by the UNICEF/UNDP/World Bank/WHO
>> Special Programme for Research and Training in Tropical Diseases:
>> Chagas disease, dengue and dengue haemorrhagic fever, leishmaniasis,
>> leprosy, lymphatic filariasis, malaria, onchocerciasis,
>> schistosomiasis and human African trypanosomiasis."
>>
>>
>
>
> --
> Judit Rius Sanjuan
> Attorney
> judit.rius@keionline.org
>
> Knowledge Ecology International (KEI)
> www.keionline.org / www.cptech.org
> 1621 Connecticut Ave, NW, Suite 500 Washington, DC 20009 USA
> Tel.: +1.202.332.2670, Ext 18  Fax: +1.202.332.2673
>
> _______________________________________________
> Ip-health mailing list
> Ip-health@lists.essential.org
> http://lists.essential.org/mailman/listinfo/ip-health
>


--
Judit Rius Sanjuan
Attorney
judit.rius@keionline.org

Knowledge Ecology International (KEI)
www.keionline.org / www.cptech.org
1621 Connecticut Ave, NW, Suite 500 Washington, DC 20009 USA
Tel.: +1.202.332.2670, Ext 18  Fax: +1.202.332.2673